EECP therapy available in Government Hospital in India

In India patients will be able to avail treatment using an enhanced external counter pulsation (EECP) equipment at the Mahatma Gandhi Memorial (MGM) government hospital in Trichy from Saturday onwards. EECP is a non invasive treatment for patients with refractory cardiac failure, refractory angina, angina after bypass surgery, patients unwilling or unfit for surgery and … Continue reading EECP therapy available in Government Hospital in India

A Surgical Robot Dedicated to Patients in Canada the Montreal Heart Institute

A Surgical Robot Dedicated to Patients Undergoing Coronary Artery Bypass Cardiac and Surgery Mitral Valve The Montreal Heart Institute (MHI) is proud to announce the acquisition of the da Vinci Xi, a new generation surgical robot, and the first in Canada to be exclusively dedicated to cardiac surgery. “The development of robotic cardiac surgery plays … Continue reading A Surgical Robot Dedicated to Patients in Canada the Montreal Heart Institute

$12 Million investment for Endotronix on Wireless Heart Monitoring

CEO Harry Rowland from Endotronix said in a statement. “We look forward to advancing our clinical program with proactive heart failure management that simplifies at-home care and improves patient outcomes.” Endotronix aims to improve patient care and reduce the cost of treating patients with heart failure by giving doctors a heads up about changes in blood … Continue reading $12 Million investment for Endotronix on Wireless Heart Monitoring

Impella Circulatory Support Device No Benefits in Cardiogenic Shock

New results from a prospective, randomized, multi-center trial of the Impella CP heart pump (Abiomed) versus intra-aortic balloon (IAB) counterpulsation in patients with cardiogenic shock demonstrated no improvement in mortality with the Impella CP device and significantly more bleeding and hemolysis complications. The data were recently presented at the 28th Annual Transcatheter Cardiovascular Therapeutics (TCT) … Continue reading Impella Circulatory Support Device No Benefits in Cardiogenic Shock

ST. JUDE & ABBOTT to sell portion of vascular closure and electrophysiology business to TERUMO

ABBOTT’S ACQUISITION OF ST. JUDE MEDICAL IS EXPECTED TO CLOSE BY YEAR-END THE AGREEMENT IS AN IMPORTANT STEP TOWARD COMPLETION OF ABBOTT’S ACQUISITION OF ST. JUDE MEDICAL Abbott (NYSE: ABT) and St. Jude Medical, Inc. (NYSE: STJ) announced today an agreement in principle to sell certain products to Terumo Corporation. The transaction reflects a purchase … Continue reading ST. JUDE & ABBOTT to sell portion of vascular closure and electrophysiology business to TERUMO

Jarvik Heart Receives FDA Approval for Clinical Trial of Miniature Heart Assist Device for Infants and Children

The U.S. Food and Drug Administration has granted conditional approval to conduct an Investigational Device Exemption study of Jarvik Heart’s new miniature Left Ventricular Assist Device (LVAD) System. The study will compare the implanted, portable electrically-powered Jarvik 15mm LVAD System with the Berlin Heart EXCOR Pediatric System. Jarvik Heart, Inc. is the manufacturer of the … Continue reading Jarvik Heart Receives FDA Approval for Clinical Trial of Miniature Heart Assist Device for Infants and Children

Abiomed: Approval received for Japan approval for its Impella 2.5 and Impella 5.0 heart pumps.

The approved devices are cannulas blood pumps, designed for acute heart failure (cardiogenic shock). Abiomed is opening a larger office in Tokyo, recruiting for clinical support staff, and submitting for Japanese reimbursement in the near future. A rigorous on-site training and certification program is planned including physician proctoring. Abiomed plans to start supporting patients in … Continue reading Abiomed: Approval received for Japan approval for its Impella 2.5 and Impella 5.0 heart pumps.

Intra-Aortic Circulatory Support Pump with Aortix Minimally Invasive technic

Over 6 million people are affected by Heart failure in the US alone. Every year, 660,000 new cases are diagnosed and more than 1 million hospitalizations occur, with a cost approaching $35 billion. For 2 million of these patients (US), drugs can no longer control the problem and, in most cases, the only options remaining … Continue reading Intra-Aortic Circulatory Support Pump with Aortix Minimally Invasive technic